Analex Corporation confirmed that its common stock will begin trading on the American Stock Exchange (Amex) today, under the symbol "NLX."
Analex executives, Jon Stout, Chairman, Sterling Phillips, President and CEO, and Ron Alexander, Chief Financial Officer, will attend opening ceremonies at the Amex, where they will ring the opening bell to celebrate the listing of the Company's common stock. Links to view this bell ringing ceremony live will be available starting at 9:20 a.m. (ET) on the Amex website, http://www.amex.com/.
Analex specializes in developing intelligence, systems engineering and biodefense solutions in support of our nation's security. Analex focuses on developing innovative technical solutions for the intelligence community, analyzing and supporting defense systems, designing, developing and testing aerospace systems and developing medical defenses and treatments for infectious agents used in biological warfare and terrorism. The Company's stock formerly traded on the OTC Electronic Bulletin Board under the symbol ANLX. The Company can be found on the Internet at www.analex.com. Analex investor relations can be contacted at (703) 329-9400 or via email at amber.gordon@analex.com.
PLEASE NOTE: Except for the historical information contained herein, this press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, that involve a number of risks and uncertainties. These forward-looking statements may be identified by reference to a future period by use of forward-looking terminology such as "anticipate," "expect," "could," "intend," "may" and other words of a similar nature. There are certain important factors and risks that could cause results to differ materially from those anticipated by the statements contained herein. Such factors and risks include business conditions and growth in the medical research, pharmaceutical and government contracting arenas and in the economy in general. Competitive factors include the pressures toward consolidation of small government contracts into larger contracts awarded to major, multi-national corporations; and the Company's ability to continue to recruit and retain highly skilled scientific, technical, managerial and sales/marketing personnel. Other risks may be detailed from time to time in the Company's filings with the Securities and Exchange Commission. Analex undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
CONTACT: Amber Gordon and Sterling Phillips, both of Analex Corporation, +1-703-329-9400
Web site: http://www.analex.com/
No comments:
Post a Comment